Form 8-K - Current report:
SEC Accession No. 0001193125-25-142747
Filing Date
2025-06-18
Accepted
2025-06-18 16:31:30
Documents
12
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d48423d8k.htm   iXBRL 8-K 30728
  Complete submission text file 0001193125-25-142747.txt   145476

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sepn-20250617.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sepn-20250617_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sepn-20250617_pre.xml EX-101.PRE 11261
14 EXTRACTED XBRL INSTANCE DOCUMENT d48423d8k_htm.xml XML 3635
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42382 | Film No.: 251057375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)